Skip to main content

Table 1 Overview of potential economic effects of the reviewed antibiotics

From: Multiresistant bacteria and current therapy - the economical side of the story

Parameter

Linezolid

Daptomycin

Doripenem

Tigecycline

LOS

X

X

X

 

HMV

  

X

 

ICU days

    

Isolation

    

Complications

 

X

  

Early choice

    

IV-to-oral switch

X

  

(X)*

Duration of therapy

X

(X)

 

(X)

Combination therapy

   

X

Adherence to guidelines

    
  1. *Tigecycline may have positive effects on drug costs when used as monotherapy.
  2. X = potential reduction of total treatment cost.